Gulf International Bank UK Ltd boosted its stake in shares of MetLife Inc. (NYSE:MET) by 0.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 284,315 shares of the company’s stock after buying an additional 400 shares during the period. Gulf International Bank UK Ltd’s holdings in MetLife were worth $12,632,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. First Republic Investment Management Inc. boosted its position in shares of MetLife by 36.1% in the first quarter. First Republic Investment Management Inc. now owns 68,830 shares of the company’s stock valued at $3,024,000 after buying an additional 18,275 shares in the last quarter. Fulton Bank N.A. purchased a new position in shares of MetLife during the second quarter valued at approximately $219,000. Park National Corp OH boosted its position in shares of MetLife by 7.9% in the second quarter. Park National Corp OH now owns 7,317 shares of the company’s stock valued at $292,000 after buying an additional 536 shares in the last quarter. Carl Domino Inc boosted its position in shares of MetLife by 197.1% in the second quarter. Carl Domino Inc now owns 20,025 shares of the company’s stock valued at $798,000 after buying an additional 13,285 shares in the last quarter. Finally, Osborn Rohs Williams & Donohoe Ltd boosted its position in shares of MetLife by 15.2% in the second quarter. Osborn Rohs Williams & Donohoe Ltd now owns 6,053 shares of the company’s stock valued at $241,000 after buying an additional 800 shares in the last quarter. 74.19% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Shares of MetLife Inc. (NYSE:MET) traded down 1.80% on Monday, reaching $54.45. 5,350,205 shares of the company’s stock were exchanged. The company’s 50 day moving average is $49.49 and its 200-day moving average is $44.38. MetLife Inc. has a one year low of $35.00 and a one year high of $55.49. The stock has a market cap of $59.85 billion, a price-to-earnings ratio of 16.73 and a beta of 1.66.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, November 2nd. The company reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.04. MetLife had a net margin of 5.58% and a return on equity of 6.99%. The firm earned $17.70 billion during the quarter, compared to analyst estimates of $17.03 billion. During the same period last year, the firm posted $0.62 earnings per share. MetLife’s revenue for the quarter was down 99.9% compared to the same quarter last year. On average, analysts anticipate that MetLife Inc. will post $4.63 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Monday, November 7th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date is Thursday, November 3rd. MetLife’s dividend payout ratio (DPR) is presently 49.23%.

COPYRIGHT VIOLATION NOTICE: “MetLife Inc. (MET) Position Raised by Gulf International Bank UK Ltd” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/28/metlife-inc-met-position-raised-by-gulf-international-bank-uk-ltd.html.

Several equities research analysts have issued reports on the stock. TheStreet lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Wednesday, August 24th. FBR & Co lifted their target price on shares of MetLife from $51.00 to $54.00 and gave the company an “outperform” rating in a research report on Monday, August 29th. Argus reiterated a “buy” rating and set a $54.00 target price on shares of MetLife in a research report on Wednesday, September 7th. Wells Fargo & Co. reiterated an “outperform” rating on shares of MetLife in a research report on Friday, September 23rd. Finally, Credit Suisse Group AG assumed coverage on shares of MetLife in a research report on Friday, October 7th. They set a “neutral” rating and a $51.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $51.35.

In related news, EVP Maria R. Morris sold 8,800 shares of the firm’s stock in a transaction on Tuesday, October 4th. The stock was sold at an average price of $45.00, for a total value of $396,000.00. Following the completion of the sale, the executive vice president now directly owns 116,409 shares in the company, valued at $5,238,405. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Frans Hijkoop sold 56,250 shares of the firm’s stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $51.48, for a total value of $2,895,750.00. Following the completion of the sale, the executive vice president now owns 111,813 shares of the company’s stock, valued at $5,756,133.24. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

MetLife Company Profile

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.